Is the Definition of Value in Healthcare Changing? Sessions on the Agenda at ISPOR Europe 2026
2026/11/05 | The Evidence Base
What Will It Take for RWE to Become Decision-Grade? Sessions on the Agenda at ISPOR Europe 2026
2026/11/05 | The Evidence Base
One Year Into JCA, What Have We Learned and What Comes Next? Sessions on the Agenda at ISPOR Europe 2026
2026/11/05 | The Evidence Base
From Defining Value to Reshaping Evidence: What to Expect From the ISPOR Europe 2026 Plenary Sessions
2026/10/30 | The Evidence Base
ISPOR Europe 2026 Plenaries Announced
2026/10/30 | ISPOR
Insurer Data Suggest AI Coding Tools in Hospitals Boost Costs By Nearly $1B
2026/10/13 | Blue Cross Blue Shield
US Medicare Pricing Policies Could Drive Global Costs, Hinder Access Worldwide
2026/10/13 | Health Policy Watch
China Taps Real-World Evidence for New Drug Valuation, Informed Decision Making
2026/10/13 | Drug Information Association
Model Finds Afghan Medical Education Ban for Women Will Impact Health Outcomes
2026/10/13 | Lancet Global Health
Cost-Effectiveness Analysis Supports National Typhoid Vaccination in Indonesia
2026/10/13 | Vaccine
In Jordan, Realizing HTA’s Potential Will Involve Systemic, Methodological Barriers
2026/10/13 | Technology Assessment in Health Care
Analysis Highlights Impact of Tobacco-Tax Reforms on Countries’ Smoking Rates
2026/10/13 | World Health Organization
Low Breast Cancer Screening Rates Persist in Historically Redlined Neighborhoods
2026/10/13 | JAMA Network Open
Model Finds Florida’s Proposed Measles Policy Shift Could Trigger Historic Epidemic
2026/10/13 | PNAS
Report Calls for Stronger Cardiovascular Patient Partnerships in Asia-Pacific Region
2026/10/13 | Global Heart Hub
New Members of US Preventive Services Task Force Include 5 Physician Specialists
2026/10/13 | The Hill
Glucose-Lowering Drug Adherence Reduces Cardiovascular Risk in Danish Study
2026/10/13 | Lancet Regional Health-Europe
Cost-Effectiveness Analysis Supports Biofortification of Staple Crops in LMICs
2026/10/13 | Journal of Nutrition
Report Estimates Generics and Biosimilars Saved US Healthcare $496B in 2025
2026/10/13 | Association for Accessible Medicines
- 1
- 2
- 3 (current)
- 4
- 5
Subscribe to the HEOR News Desk
SubscribeAlready have an ISPOR Profile? Click here to manage your subscriptions.
